REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
12/29/2025
Back to search
Official data from USPTO
CARDIO RENAL
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: CombinedOffice: United States
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
27
Latest update
12/30/2025
Trademark type
Combined
Nice classes
10, 42, 44
Filing date
10/31/2019
Registration date
12/29/2020
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/29/2020
Last transaction
12/30/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Drawing code
3
Owner type
34
Owner location
FR
Examiner
MCDOWELL,MATTHEW J
Law office
L10
Current location
PUBLICATION AND ISSUE SECTION
Mark description
The mark consists of the words "CARDIO" and "RENAL" in white. The words appear inside two drops, one drop in gray containing the word "cardio", the other in blue containing the word "renal". A white line separates the two drops. A stylized representation of three blue soundwaves appear to the right of the blue drop.
Holders and representatives
Holders
CARDIORENAL
Representatives
Pina M. Campagna Carter, DeLuca, & Farrell, LLP
Technical classification
Nice Classes
Class 10Class 42Class 44
Vienna Codes
No Vienna codes available.
Goods and services
Class 10
Medical devices for monitoring cardiovascular diseases and renal diseases; medical monitoring devices for cardiovascular diseases and renal diseases; medical monitoring devices for cardiovascular failure and renal failure; heart rate monitors; medical instruments for recording and transmission of heart and kidney activity; apparatus and instruments for collecting and analyzing blood; lancets for blood samples
Class 42
Services for designdevelopmentupdates and maintenance of softwaresoftware applications and software platforms; services for designdevelopmentupdates and maintenance of computer software incorporating algorithms; design and writing of computer programs in the medical field; design and writing of computer programs for medical applications; design and development of computer software for use in the framework of medical technology; development of computerized information systems using artificial intelligence technology for medical use; design and development of medical technologies for heart failure disease; providing scientific research for medical purposes in the field of heart failure disease; design and development of medical equipment used for medical diagnostic and medical monitoring purposes; development and testing of computer software and computer algorithms for use in establishing clinical research methodologies; design of computer database software; computer database design and development; maintenance of computer software databases; software as a service SaaS services featuring software for use in developing medical diagnostic tools in the field of heart failure disease; Computer platform as a service PaaS featuring computer software platforms for use in developing medical diagnostic tools in the field of heart failure disease; providing clinical research services in the field of heart failure disease; providing medical research services in the field of heart failure disease; providing scientific advisory services in the field of heart failure disease; Providing laboratory research services in the field of heart failure disease; providing automated biological research and analysis
Class 44
Trans-telephonic heart monitoring services; Providing medical information in the field of heart failure disease; Medical patient diagnostic testingmonitoring and evaluation services; medical assistance; medical consultations; emergency medical assistance; Medical analysis services for diagnostic and treatment purposes provided by medical laboratories; telemedicine services; Providing an internet-based database of patient medical information supported by artificial intelligence software where patients can inquire about medical diagnosis and treatment optionsobtain personalized medical decision assistance services and receive follow up monitoring to determine efficacy of treatment provided; Technical support servicestroubleshooting in the nature of diagnosing problems with medical equipment as it relates to patient health; Medical consulting services in the proper use and applicability of medical treatment devices; Medical screening information services featuring reminder alerts regarding medical examinations that individuals should undergo for both continuing assessment and preventive care purposes; Providing medical information with respect to proper use and applicability of medical treatment devices
Publications
History of USPTO decisions and trademark events.
27 publications found
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
04/24/2021
FICS
FINAL DISPOSITION NOTICE SENT TO IB
04/01/2021
FIMP
FINAL DISPOSITION PROCESSED
04/01/2021
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
03/29/2021
R.PR
REGISTERED-PRINCIPAL REGISTER
12/29/2020
GPNX
NOTIFICATION PROCESSED BY IB
10/18/2020
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
10/13/2020
PUBO
PUBLISHED FOR OPPOSITION
10/13/2020
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
09/30/2020
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
09/30/2020
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
09/23/2020
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
09/08/2020
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/04/2020
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/03/2020
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/03/2020
DOCK
ASSIGNED TO EXAMINER
06/04/2020
NREP
NEW REPRESENTATIVE AT IB RECEIVED
05/07/2020
RFNT
REFUSAL PROCESSED BY IB
03/27/2020
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
03/05/2020
RFRR
REFUSAL PROCESSED BY MPU
03/05/2020
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
02/12/2020
CNRT
NON-FINAL ACTION WRITTEN
02/11/2020
DOCK
ASSIGNED TO EXAMINER
02/05/2020
MAFR
APPLICATION FILING RECEIPT MAILED
01/18/2020
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/14/2020
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
01/09/2020
Continuous trademark protection
Get notified about every new filing that threatens CARDIO RENAL or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.